2024 in review: Celebrating biotech innovation and milestones with our clients
Reflecting on 2024, the biotech industry considerably advanced in gene editing, oncology, and AI-driven drug discovery and saw increased M&A activity. We also witnessed a notable shift toward immunology, with […]